R. Behal

Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial

Lise J Estcourt, Zoe McQuilten, Peter Bardy, Merrole Cole‐Sinclair et autres

Variation in the host ABO blood group may be associated with susceptibility to hepatitis C virus infection

R. Behal, Rahul Jain, Krishan K. Behal, T.N. Dhole

This study aimed to determine the relationship between hepatitis C virus (HCV) infection and ABO/Rhesus blood groups, age and sex. A total of 20 000 patients who came to donate blood in the blood bank of GSVM Medical College, Kanpur were enrolled …

in (code pays fourni par la source)

PP-075 Seroprevalence of hepatitis C virus infection in Northern India and its association with blood groups, sex and age

R. Behal, Ravi Jain, Krishan K. Behal

Methods: The yeast expression vectors of different spliceosomes and deletion mutants of CAML gene was constructed and transfected into yeast Y187, matching experiment with AH109 transfected pGBKT7-NS4A was performed. Diploid yeast was plated on synthetic dropout nutrient medium (SD/-Trp-Leu-His-Ade) containing X-a-gal. Results: …

PP-014 Entecavir treatment of chronic hepatitis B patients who are exposed to lamivudine

R. Behal, Piyush Upadhyay, Piyush Srivastava, T.S. Negi et autres

Seroprevalence and risk factors for hepatitis B virus infection among general population in Northern India

R. Behal, Renu Jain, Krishan K. Behal, Ajay Bhagoliwal et autres

BACKGROUND: Infection with hepatitis-B virus has been a significant cause of morbidity claiming more than a million lives every year. Epidemiological data reveals that there are 360 million carriers of hepatitis-B virus throughout the globe and 78% of the world populations' hail …

in, fr (code pays fourni par la source)

600 DO BLOOD GROUP PLAY A ROLE IN HEPATITIS C VIRUS INFECTION?

R. Behal, Rubal Jain, Krishan K. Behal, T.N. Dhole

in, us, es (code pays fourni par la source)

Status of HBsAg and HCV in blood doners

R. Behal